Inventor · disambiguated record
Lisa E. Hensley
Also filed as: HENSLEY LISA · HENSLEY LISA E
7 granted patents·4 pending applications·320 citations·filing 2006–2025
87Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC3FRIEMAN MATTHEW1GEISBERT THOMAS W1MACLACHLAN IAN1ROBBINS MARJORIE1
Top patents by PatentIndex Score
11 records- 0197US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 0295US7838658B2siRNA silencing of filovirus gene expressionMACLACHLAN IAN·Filed 2006·Granted Nov 23, 2010·181 cites·45 claims
- 0390US8716464B2Compositions and methods for silencing Ebola virus gene expressionGEISBERT THOMAS W·Filed 2010·Granted May 6, 2014·11 cites·20 claims
- 0488US8455455B1Compositions and methods for silencing genes involved in hemorrhagic feverROBBINS MARJORIE·Filed 2011·Granted Jun 4, 2013·23 cites·30 claims
- 0580US11041170B2Multivalent vaccines for rabies virus and coronavirusesTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2017·Granted Jun 22, 2021·2 cites·22 claims
- 0678US10434116B2Methods of treating coronavirus infectionFRIEMAN MATTHEW·Filed 2015·Granted Oct 8, 2019·10 cites·7 claims
- 0765US12269155B2Multivalent vaccines for rabies virus and coronavirusesUS HEALTH·Filed 2021·Granted Apr 8, 2025·0 cites·24 claims
- 0860US2025290927A1Peptides and peptide microarrays for detection and differentiation of antibody responses to ebola virusUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 0955US2016264971A1Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1047US2011177131A1siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1130US2011027388A1Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola VirusUS GOV SEC NAVY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lisa E. Hensley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →